Koers Stemcell Holdings, Inc. Other OTC
Aandelen
STMM
US85858N2027
Farmaceutische producten
Omzet 2016 | 3,34 mln. 3,1 mln. | Omzet 2017 | 6,18 mln. 5,73 mln. | Marktkapitalisatie | 1,64 mln. 1,52 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2016 | 1 mln. 928K | Nettowinst (verlies) 2017 | 2 mln. 1,86 mln. | EV/omzet 2016 * | - |
Nettoliquiditeiten 2016 * | - 0 | Nettoliquiditeiten 2017 * | - 0 | EV/omzet 2017 * | - |
K/w-verhouding 2016 * |
-
| K/w-verhouding 2017 * |
-
| Werknemers | - |
Dividendrendement 2016 * |
-
| Dividendrendement 2017 * |
-
| Vrij verhandelbaar | 99% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+2,88% | 93,97 mld. | |
+6,58% | 41,61 mld. | |
-13,20% | 33,32 mld. | |
+77,12% | 28,8 mld. | |
-16,02% | 15,61 mld. | |
-8,17% | 13,27 mld. | |
-12,49% | 11,46 mld. | |
+162,44% | 10,06 mld. | |
-54,92% | 9,09 mld. |